助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   chronic fulminant hepatitis 的翻译结果: 查询用时:0.01秒
图标索引 在分类学科中查询
所有学科
消化系统疾病
感染性疾病及传染病
更多类别查询

图标索引 历史查询
 

chronic fulminant hepatitis
相关语句
  慢性重型肝炎
     There was no significant difference in the serum levels of HBV DNA between the group of chronic fulminant hepatitis B(107.3731±1.4381copies/ml) and the non-fulminant group(106.6516±1.8046copies/ml).
     慢性重型肝炎组HBV DNA含量(107.3731±1.4381copies/ml)与非慢性重型肝炎组HBV DNA含量(106.6516±1.8046copies/ml)比较差异无统计学意义(P>0.05);
短句来源
     Results The positive rate of mutants in chronic fulminant hepatitis and in non-fulminant groups was 70.0%(15/25) and 33.6%(44/131),respectively(P=0.023).
     结果HBV BCP变异在慢性重型肝炎组的阳性率为60.0%(15/25)显著高于非重型肝炎组的33.6%(44/131)(P=0.023);
短句来源
     Conclusions Serum AST/ALT ratio,total bilirubin,PTA,TC,Buche and ALB are important factors to prognose the chronic fulminant hepatitis.
     结论 血清AST/ALT的比值、总胆红素、PTA、TC、Buche、及ALB是预测慢性重型肝炎预后的重要指标。
短句来源
     Analysis of influencing factors on efficacy of plasma exchange in the treatment of chronic fulminant hepatitis
     血浆置换治疗慢性重型肝炎影响疗效的因素分析
短句来源
     Analysis influence factors on efficacy of Plasma exchange for the treatment of Chronic Fulminant hepatitis
     血浆置换治疗慢性重型肝炎疗效影响因素分析
更多       
  慢性重症肝炎
     Clinical characters of chronic fulminant hepatitis
     慢性重症肝炎的临床特点
短句来源
     Conclusion Thymosin α_1 can effectively cure chronic fulminant hepatitis complicated by SBP with improvement in the patient's prognosis.
     结论胸腺素α1可有效治疗慢性重症肝炎并发自发性细菌性腹膜炎,改善患者预后。
短句来源
     There was no statistic difference between chronic mild,middle and severe hepatitis B,liver cirrhotic and chronic fulminant hepatitis(P>0 05).
     不同临床类型 HBV感染者 HBV DNA含量 :慢性肝炎轻、中、重度 ,肝炎后肝硬化 ,慢性重症肝炎 5组间无显著性差异 (P >0 .0 5 )。
短句来源
     Objective:To investigate the mutant significance of HBV BCP in patients with chronic fulminant hepatitis B. Methods:Mutants (nt1?762A→T and 1?764G→A) of HBV BCP in 74 patients with chronic hepatitis B virus infection were studied by polymerase chain reaction combined with ELISA. Results:The T 1?
     目的 :探讨乙型肝炎病毒慢性感染中C基因启动子 (BCP)变异与慢性重症肝炎的关系。 方法 :采用PCR微板核酸杂交结合ELISA检测显示技术 ,检测 74例乙型肝炎病毒慢性感染者BCP区核苷酸 (nt) 176 2碱基A→T和 176 4碱基G→A联合突变。
短句来源
     Clinical Application of Fat Emulsion in the Treatment of the Chronic Fulminant Hepatitis
     脂肪乳剂在慢性重症肝炎治疗中的临床应用探讨
短句来源
更多       
  慢重肝炎
     Objectives To investigate the effects of fat emulsion on the liver functions and the prognois of chronic fulminant hepatitis.
     目的研究脂肪乳剂在治疗慢重肝炎对肝功能和疾病预后的影响。
短句来源
  “chronic fulminant hepatitis”译为未确定词的双语例句
     There was no statistical difference in HBeAg rate between genotype B and C in general, but in patients with chronic fulminant hepatitis or aged 21~30, the HBeAg rates of genotype C (35.0% and 50.0%) were significantly higher than those of genotype B (14.4% and 24.5%) (P<0.05).
     B ,C两型的HBeAg阳性率总体无差别 ,但在慢性重型以及 2 130岁年龄段的患者中 ,C型的HBeAg阳性率 (35 .0 %和 5 0 .0 % )均显著高于B型 (14 .4 %和 2 4 .5 % ) (均P <0 .0 5 )。
短句来源
     Results 61cases (76.5%) developed bacterial infection in total of 68 cases with chronic fulminant hepatitis B and 33 cases developed bacterial infection in more than 2 sites.
     结果68例病人中发生继发感染者61例(76.5%),其中33例出现2个以上部位感染。
短句来源
     [Objective] To study the relationship between the expression of NKG2D gene in immunocytes and the severity of patients with chronic hepatitis B.[Methods] Blood samples were obtained from 20 patients with chronic fulminant hepatitis B,10 with asymtomatic surface antigen carriers and 10 healthy people(control group). NK cells were sorted and expression of NKG2D gene were quantitatively determined by Flow cytometry and immunofluorescent techniques.
     目的分析乙型肝炎免疫细胞NKG2D表达与肝病重型化的关系。 方法应用免疫荧光技术和流式细胞术(FCM)分选20例慢性重型乙肝(FHB)、10例无症状表面抗原携带者(ASC)、10例健康对照的外周血NK细胞,并定量分析NKG2D表达。
短句来源
     762 and A 1? 764 mutant in HBV BCP region were found in 24(24/74) patients. The positivity rates of mutant in chronic fulminant hepatitis B and in non-fulminant groups were 63.6%(7/11) and 27%(17/63) respectively ( P <0.05).
     结果 :在 74例乙型肝炎病毒慢性感染者中检出BCP区T176 2A突变 2 4例 (32 .4 % ) ,BCP变异在重症肝炎的发生率为 6 3.6 % (7/ 11)显著高于非重症肝炎的发生率 2 7% (17/ 6 3) (P<0 .0 5 )。
短句来源
     Clinical behavior of secondary bacterial infection in patients with chronic fulminant hepatitis B
     慢性乙型重型肝炎继发性感染的临床特点
短句来源
更多       
查询“chronic fulminant hepatitis”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
没有找到相关例句


61 cases with fulminant hepatitis were treated with traditional therapy (Group Ⅰ), combined therapy (Group Ⅱ) and combined therapy with anisodamine (Group) Ⅲ respectively. The results showed that the mortality of group Ⅱ(42.86%) and group Ⅲ(31.82%) was much lower thau than of group Ⅰ (88.89%). P<0.01; compared with group Ⅰ the incidence of complications was lower and the average survival time of the dead cases in much longer in group Ⅱ and group Ⅲ; The mortality of chronic fulminant hepatitis in group...

61 cases with fulminant hepatitis were treated with traditional therapy (Group Ⅰ), combined therapy (Group Ⅱ) and combined therapy with anisodamine (Group) Ⅲ respectively. The results showed that the mortality of group Ⅱ(42.86%) and group Ⅲ(31.82%) was much lower thau than of group Ⅰ (88.89%). P<0.01; compared with group Ⅰ the incidence of complications was lower and the average survival time of the dead cases in much longer in group Ⅱ and group Ⅲ; The mortality of chronic fulminant hepatitis in group Ⅲ was lower than that of group Ⅰ (P<0.01) and group Ⅱ (P<0.05)

对61例各型重症病毒性肝炎(以下简称重肝)采用一般支持疗法、综合疗法、综合疗法加山茛菪碱治疗。结果:后两组病死率分别为42.86%、31.82%,明显低于一般支持疗法组病死率(88.89%P<0.01)。死亡病例平均存活时间亦较一般支持疗法明显延长。并发症减少。且综合疗法加山茛菪碱可降低慢重肝死亡率,优于一般疗法与单纯综合治疗组。

In this report, sera of fulminant hepatitis were detected for sero-etiologic and leves of tumor necrosis factor by means of ELISA, in 45 patients with fulminant hepatitis (5 patients with acute fulminant and 40 patients with chronic fulminant hepatitis). The results were as follows: HBV is the major etiology of fulminant hepatitis in Bejijng arca, up to 97.7%, and superinfection is a key of fulminant hepatitis occurrence, up to 80%, with a mortality of 53.3%. Superinfection and...

In this report, sera of fulminant hepatitis were detected for sero-etiologic and leves of tumor necrosis factor by means of ELISA, in 45 patients with fulminant hepatitis (5 patients with acute fulminant and 40 patients with chronic fulminant hepatitis). The results were as follows: HBV is the major etiology of fulminant hepatitis in Bejijng arca, up to 97.7%, and superinfection is a key of fulminant hepatitis occurrence, up to 80%, with a mortality of 53.3%. Superinfection and tumor necrosis factor levels are important of factors that affects prognosis of fulminant hepatitis.

用酶联免疫吸附试验(ELISA)方法对45例重型肝炎,其中急性重型肝炎3例,亚急性重型肝炎2例,慢性重型肝炎40例,病原学及血清肿瘤坏死因子(TNF)水平检测分析。认为乙型肝炎病毒(HBV)感染是北京地区重型肝炎的主要病原,可达97.5%;不同肝炎病毒重叠感染是重型肝炎发生的关键,占80%,其死亡率达53.3%。不同肝炎病毒重叠感染及TNF水平是影响重型肝炎预后的最重要因素。上述因素的检测分析,对认识重型肝炎发生、发展、转归和指导临床治疗具有重要意义。

The distribution of T cell subpopulation and the concentration of serum soluble interleukin-2(SIL-2R) receptor were determined in 151 patients with chronic hepalitis B by an APAAP immune-bridge assay and a double-antibodies ELISA. The date showed that the number of CD3, CD4 and the ratio of CD4 to CD8 were significantly lower, and the number of CD8 was significantly increased in patients with chronic hepatitis B, and indicated the disorders of T lymphatic cell proportion and cell immune adjustment function in...

The distribution of T cell subpopulation and the concentration of serum soluble interleukin-2(SIL-2R) receptor were determined in 151 patients with chronic hepalitis B by an APAAP immune-bridge assay and a double-antibodies ELISA. The date showed that the number of CD3, CD4 and the ratio of CD4 to CD8 were significantly lower, and the number of CD8 was significantly increased in patients with chronic hepatitis B, and indicated the disorders of T lymphatic cell proportion and cell immune adjustment function in these patients.The level of SIL-2R was also significantly higher in all patients, especially in patients with chronic fulminant hepatitis or chronic active hepatitis, and reflected on the conditions of human immune function and hepatic cell lesions. This present data suggest that the combined analyses of T cell subpopulation and SIL-2R may be an important value in clinical type and prognosis of liver diseases in patients with chronic hepatitis B.

应用APAAP免疫酶桥法及双抗体夹心ELISA法测定151例慢性乙型肝炎患者外周血T淋巴细胞亚群和血清可溶性白细胞介素-2受体(SIL-2R)。结果显示,慢乙肝患者CD3、CD4、CD4/CD8比值明显降低,CD8则明显升高。表明慢乙肝患者体内存在T淋巴细胞比例失衡,细胞免疫调控功能紊乱。慢乙肝患者血清SIL-2R水平均显著升高,其中以慢重肝和慢活肝升高最为显著,提示SIL-2R水平高低能反映机体免疫功能状态及肝细胞损伤程度。T细胞亚群和SIL-2R联合检测对慢乙肝患者病值变化、临床诊断分型及预后判断有重要价值。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关chronic fulminant hepatitis的内容
在知识搜索中查有关chronic fulminant hepatitis的内容
在数字搜索中查有关chronic fulminant hepatitis的内容
在概念知识元中查有关chronic fulminant hepatitis的内容
在学术趋势中查有关chronic fulminant hepatitis的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社